Loading...

GOVX GEOVAX LABS INC Investments/Divestments 8-K Filing

GVX

GVX

GEOVAX LABS INC

(GOVX)

2024 8-K

Show Summary

Show Summary

Financial Statements

Contract Termination

Earnings Report

Stockholder Approvals

Special Meeting Update

Nasdaq Compliance

Quarterly Results

Stockholder Meeting

Share Offering Increase

Stockholder Meeting

Stock Sale Agreement

Stockholder Meeting

Earnings Report

Investment Offering

Award for COVID-19 Vaccine ...

Amendment to Bylaws and Ann...

Investment Offering

Results of Operations and F...

Earnings Report

Reverse Stock Split

Stockholder Meeting

Agreement with Existing War...

Earnings Reports

Earnings Reports

Annual Meeting Results

Equity Offerings

Earnings Reports

External Links:

GeoVax received a $24.3 million award from BARDA to advance development of their COVID-19 vaccine in a Phase 2b clinical trial.

AI Assistant

GEOVAX LABS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.